Skip to content
Verana-logo-horizontal-5
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us
VeranaHealth_Logo
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us

Research

Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System: A Subgroup Analysis from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)

November 3, 2025
Read More...

Contemporary Trends of Benign Prostatic Hyperplasia Procedures in the AUA Quality Registry: Are We Moving the Needle Toward More Minimally Invasive Treatments?

May 29, 2025
Read More...

A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence

May 29, 2025
Read More...

Who Progresses to Third-Line Therapies for Overactive Bladder? Trends From the AQUA Registry

May 29, 2025
Read More...

Choice of First Medication Prescribed For Overactive Bladder Changes With Time: Trends From The AUA AQUA Registry

May 29, 2025
Read More...

Factors Influencing Medication Selection for Management of Overactive Bladder: Trends and Insights From AUA Quality Registry

May 29, 2025
Read More...

Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US

May 29, 2025
Read More...

Early Outcomes After Initiation of Faricimab for Neovascular Age-Related Macular Degeneration

May 21, 2025
Read More...

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema”

December 13, 2024
Read More...

Functional Outcomes and Quality of Life in Geographic Atrophy in the Clinical Setting

November 13, 2024
Read More...
  • 1
  • 2
  • 3
  • …
  • 14
  • Next »
VeranaHealth_Logo

San Francisco | New York | Knoxville

Search

© 2025 Verana Health. All Rights Reserved.

Privacy Policy

Cookie Policy